Yesterday was World Radiotherapy Awareness Day. A day to reflect on radiotherapy’s impact.
Take a look at a recent study on how tumour irradiation can trigger immunogenic responses.
Radiotherapy is evolving beyond local control.
🔗 Read more: doi.org/10.1016/j.ra...
#RTQA
#rtqa
Want the opportunity to work at the forefront of RT #clinicaltrials? We are hiring!
Band 7 Clinical Scientist/Radiographer. 1-year post, renewable subject to funding:
www.enherts-tr.nhs.uk/careers/vaca...
Deadline 18th August.
DM for further information. #medphys #rtt #rtqa
Want to be part of shaping the future direction of RT research in the UK? An exciting opportunity has arisen to work as a research fellow within the @nihr.bsky.social RTTQA Group, based at Mount Vernon Cancer Centre.
For more info please DM us! #radonc #rtqa
www.nhsjobs.com/job/UK/Hertf...
Very excited to do the #RTQA for this trial
Proud to have contributed to this important study #RTQA
Congratulations to EORTC fellows Volha and Maria Chiara, Clinical Scientist Enrico Clementel, RTQA Officer Luiza Souza, RTQA Manager Sarah Kelly and Statistician Felix Oppong for proudly representing EORTC #RTQA team at #ESTRO25 in Vienna!
@estroradiotherapy.bsky.social #RadiationOncology
Congratulations to our very own Liz Miles, incredible colleague, mentor & friend on her #ESTRO25 Interdisciplinary Award. A true champion for #collaboration and #RTQA. So well deserved- we could not be prouder!
As some get ready for the pre-meeting courses at #ESTRO25, #RTQA @eortc.org is meeting with other RTQA experts, kindly hosted by IAEA. After missing last year I am curious to see what's been cooking in trial QA.
Regional LN delineation variability in #BrCa RT within the Fast Forward trial. Despite this variability, all mandatory constraints were adhered to. #RTQA plays a central role in providing support & guidance to participating centres
www.sciencedirect.com/science/arti...
www.sciencedirect.com/science/arti... #RTQA in PEACE 1 trial. Good compliance, main issue CTV delineation. Based on these results future prostate trials will have very light patient RTQA. Good work by Dr Alyamani, conducted as EvdS fellow at the EORTC with the support of Kom op Tegen Kanker. #radonc